EDGAR Filing Documents for 0001558370-17-001802

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-17-001802

Filing Date

2017-03-15

Accepted

2017-03-15 08:31:30

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	acrs-20161231x10k.htm	10-K	2927202
2	EX-10.24	acrs-20161231ex10246370f.htm	EX-10.24	53026
3	EX-10.25	acrs-20161231ex10258cf6d.htm	EX-10.25	34487
4	EX-23.1	acrs-20161231ex231237c9f.htm	EX-23.1	3999
5	EX-31.1	acrs-20161231ex311c7fc35.htm	EX-31.1	12622
6	EX-31.2	acrs-20161231ex312cd1806.htm	EX-31.2	13996
7	EX-32.1	acrs-20161231ex3212699d8.htm	EX-32.1	11697
8	GRAPHIC	acrs20161231ex10246370f001.jpg	GRAPHIC	84524
9	GRAPHIC	acrs20161231x10k001.jpg	GRAPHIC	51484
10	GRAPHIC	acrs20161231x10k002.jpg	GRAPHIC	27002
11	GRAPHIC	acrs20161231x10k003.jpg	GRAPHIC	29496
12	GRAPHIC	acrs20161231x10k004.jpg	GRAPHIC	31754
13	GRAPHIC	acrs20161231x10k005.jpg	GRAPHIC	27451
14	GRAPHIC	acrs20161231x10k006.jpg	GRAPHIC	29952
15	GRAPHIC	acrs20161231x10k007.jpg	GRAPHIC	27827
16	GRAPHIC	acrs20161231x10k008.jpg	GRAPHIC	27774
17	GRAPHIC	acrs20161231x10k009.jpg	GRAPHIC	30374
18	GRAPHIC	acrs20161231x10k010.jpg	GRAPHIC	18555
	Complete submission text file	0001558370-17-001802.txt		10017780

Data Files

Seq	Description	Document	Type	Size
19	EX-101.INS	acrs-20161231.xml	EX-101.INS	2044687
20	EX-101.SCH	acrs-20161231.xsd	EX-101.SCH	47380
21	EX-101.CAL	acrs-20161231_cal.xml	EX-101.CAL	55778
22	EX-101.DEF	acrs-20161231_def.xml	EX-101.DEF	179838
23	EX-101.LAB	acrs-20161231_lab.xml	EX-101.LAB	531344
24	EX-101.PRE	acrs-20161231_pre.xml	EX-101.PRE	385015

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355

Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554

Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)